Skip to main content

Bellevue Group AG

Location
Zurich, V8
Portfolio Value
Mid $4,620,113,719
Diversification
Diversified
Reports for
BB Biotech AG Bellevue Asset Management AG
Filing Date
Global Rank
#781 / 8,700 ▲ 128
Top Industry
Biotechnology 59.4%
Period ended 2 months ago
Filed Aug 14, 2026 · 30d
26 quarters · since Mar 2020

Portfolio Concentration

147 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026
Top Position
6.7%
−0.8 pts
Top 5
29.1%
+2.5 pts
Top 10
43.8%
+0.7 pts
HHI
289
Sep 2023 → Jun 2026 · range 250 – 384
Diversified+2

Portfolio Trend

26 quarters · across all stocks

Sector Breakdown

As of Jun 30, 2026
Sector % Portfolio Value
Healthcare 99.9% $4,616,199,615
Unclassified 0.0% $2,016,279
Technology 0.0% $1,191,156
Consumer Cyclical 0.0% $382,535
Communication Services 0.0% $324,134

Last Quarter's Activity

Export CSV
Jun 30, 2026 vs Mar 31, 2026

Added To

Positions the filer increased
25 positions
Ticker Δ Shares Shares Value Open

Trimmed

Positions the filer reduced
25 positions
Ticker Δ Shares Shares Value Open

New Positions

Positions the filer opened this quarter
17 positions
Ticker Shares Value Open

Sold Out

Positions the filer fully exited
25 positions
Ticker Shares Value Open
8,753 $0

Portfolio Positions

Export CSV View 13F filing
147 tracked positions · $4,620,113,719 total · filing declares 164 positions · $4,752,644,375 · as of Jun 30, 2026
Showing 1–50 of 147 positions by value · page 1 of 3
Ticker Company Shares Value (USD) % of Portfolio History

Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.